Source: Eur Respir J 2010; 36: 1073-1079
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Luján M., Gallego M., Belmonte Y., Fontanals D., Vallès J., Lisboa T., Rello J.. Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia. Eur Respir J 2010; 36: 1073-1079

Member's Comments

No comment yet.

Related content which might interest you: Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Characteristics of patients with serotype 5 pneumococcal pneumonia Source: Virtual Congress 2020 – Clinical challenges in pneumonia Year: 2020 Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 The remaining challenges of pneumococcal disease in adults Source: Eur Respir Rev 2012; 21: 57-65 Year: 2012 A study of the prevalence of streptococcus pneumoniae serotypes in patients hospitalised for community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Impact of initial antibiotic choice on mortality from pneumococcal pneumonia Source: Eur Respir J 2006; 27: 1010-1019 Year: 2006 Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults Source: Eur Respir J 2003; 21: 209-214 Year: 2003 Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia Source: Eur Respir J 2006 Oct 01;28(4):816-823 Year: 2006 Clinical features of adults with seven-valent- conjugated-vaccine- serotype pneumococcal pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Influence of streptococcus pneumoniae serotypes in clinical outcomes of pneumonias Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011 Streptococcus pneumoniae resistance pattern and its clinical implications Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes Source: Eur Respir J 2014; 43: 545-553 Year: 2013 Streptococcus pneumoniae is the main causative agent of community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 608s Year: 2002 Fast replicating strains of streptococcus pneumoniae are associated with severe community-acquired pneumonia Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany Source: Eur Respir J, 59 (2) 2102432; 10.1183/13993003.02432-2021 Year: 2022 Monitoring of Mycoplasma pneumoniae and Chlamydia pneumoniae in young patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001 Genetic diversity of pneumococcal surface protein A (PspA) in Streptococcus pneumoniae isolates from community acquired pneumonia (CAP) in china Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities Source: Virtual Congress 2021 – Pneumonia Year: 2021 Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia Source: Eur Respir J 2015; 45: 1632-1641 Year: 2015